Octreotide-Induced Bradycardia

    loading  Checking for direct PDF access through Ovid

Abstract

Because of deleterious hemodynamic effects of octreotide in a nonacromegalic patient with a pancreatic fistula, we conducted a MEDLINE search of English-language journal articles to extract information on this complication of octreotide or somatostatin therapy. Few data are available regarding patients with disease states other than acromegaly. We believe octreotide should be considered when determining the cause of bradycardia.

(Pharmacotherapy 1998;18(2):413-416)

Related Topics

    loading  Loading Related Articles